Social Prescribing and Relationship Cognitive Strategies (SPARCS)
Launched by UNIVERSITY OF MICHIGAN · Oct 22, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The study will take place at 2 University of Michigan sites.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Screen positive for either or both of the following during routine clinic screening:
- • Social isolation in the past 6 months, according to the screening question "How often do you feel isolated from others?"
- • Suicidal ideation in the past 12 months, according to the 9th item of the Patient Health Questionnaire (HQ-9) (per protocol)
- • Loneliness, according to the 3-item version of the University of California, Los Angeles (UCLA) Loneliness Scale (per protocol)
- • Are currently receiving or are able to initiate Collaborative Care Management at to participant's study site
- Exclusion Criteria:
- • Currently receiving or have an active referral for specialty mental health or substance use disorder treatment outside of primary care
- • Neurocognitively impaired according to chart diagnosis, self-report on the Eligibility Screening Survey, or inability to answer comprehension check questions during the Informed Consent process (per protocol)
- • Unable to participate in the interventions and research assessments due to planned travel or limited phone access (e.g., does not own phone)
- • Terminally ill or receiving of palliative care with less than 6 months life expectancy
About University Of Michigan
The University of Michigan, a leading academic institution renowned for its commitment to advancing healthcare and medical research, serves as a prominent clinical trial sponsor. With a robust infrastructure that supports innovative research initiatives, the university leverages its multidisciplinary expertise to conduct a wide array of clinical trials aimed at improving patient outcomes and advancing medical knowledge. Through its state-of-the-art facilities and collaborative environment, the University of Michigan fosters partnerships between researchers, clinicians, and industry leaders, ensuring the development of cutting-edge therapies and interventions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brighton, Michigan, United States
Canton, Michigan, United States
Patients applied
Trial Officials
Paul Pfeiffer, MD
Principal Investigator
University of Michigan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported